Freestone Capital Holdings’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,333	Closed	-$11.3K	–	453
2023 Q4	$11.3K	Hold	1,333	–	–	﹤0.01%	394
2023 Q3	$11.9K	Buy	+1,333	New	+$11.9K	﹤0.01%	368